Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Poseida Therapeutics, Inc. - Common Stock (NQ:PSTX)

9.500 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 7, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	9.500
Bid (Size)	9.530 (1)
Ask (Size)	9.550 (50)
Prev. Close	9.500
Today's Range	9.500 - 9.500
52wk Range	N/A - N/A
Shares Outstanding	86,916,199
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

December 20, 2024

From Halper Sadeh LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PWOD, RVNC, B, PSTX on Behalf of Shareholders

December 18, 2024

From Halper Sadeh LLC

Via GlobeNewswire

Performance

More News

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates B, ZUO, PSTX on Behalf of Shareholders

December 10, 2024

From Halper Sadeh LLC

Via GlobeNewswire

Where Poseida Therapeutics Stands With Analysts ↗

November 15, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Pactiv Evergreen Inc. (Nasdaq – PTVE), Enterprise Bancorp, Inc. (Nasdaq Global Select Market – EBTC), The Interpublic Group of Companies, Inc. (NYSE – IPG), Poseida

December 09, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, AVTE, GATO on Behalf of Shareholders

December 04, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Gatos Silver, Inc. (NYSE - GATO), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE)

December 04, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

November 29, 2024

Via Benzinga

POSEIDA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Poseida Therapeutics, Inc. - PSTX

November 27, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, ZUO, MNTX on Behalf of Shareholders

November 27, 2024

From Halper Sadeh LLC

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 26, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc.

November 26, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

Crude Oil Moves Lower; Dick's Sporting Goods Earnings Top Views ↗

November 26, 2024

Via Benzinga

Nasdaq Rises 100 Points; Abercrombie & Fitch Shares Fall After Q3 Results ↗

November 26, 2024

Via Benzinga

US Stocks Mixed; Best Buy Posts Downbeat Earnings ↗

November 26, 2024

Via Benzinga

Shareholder Alert: Ademi LLP investigates whether Poseida Therapeutics, Inc. is obtaining a Fair Price for its Public Shareholders

November 26, 2024

From Ademi LLP

Via Business Wire

Roche's Proposed Acquisition Of Poseida Therapeutics Poised To Establish New Core Capability In Cell Therapy For Cancer And Autoimmune Diseases: Details ↗

November 26, 2024

Via Benzinga

PSTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Poseida Therapeutics, Inc. Is Fair to Shareholders

November 26, 2024

From Halper Sadeh LLC

Via Business Wire

Why Poseida Therapeutics Shares Are Trading Higher By 219%; Here Are 20 Stocks Moving Premarket ↗

November 26, 2024

Via Benzinga

Best Buy, HP And 3 Stocks To Watch Heading Into Tuesday ↗

November 26, 2024

Via Benzinga

MaxCyte Appoints Cynthia Collins to its Board of Directors

October 15, 2024

From MaxCyte, Inc

Via GlobeNewswire

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 05, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 11, 2024

Via Benzinga

PSTX Stock Earnings: Poseida Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 16, 2024

Via Benzinga

Frequently Asked Questions

Is Poseida Therapeutics, Inc. - Common Stock publicly traded?

Yes, Poseida Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Poseida Therapeutics, Inc. - Common Stock trade on?

Poseida Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Poseida Therapeutics, Inc. - Common Stock?

The ticker symbol for Poseida Therapeutics, Inc. - Common Stock is PSTX on the Nasdaq Stock Market

What is the current price of Poseida Therapeutics, Inc. - Common Stock?

The current price of Poseida Therapeutics, Inc. - Common Stock is 9.500

When was Poseida Therapeutics, Inc. - Common Stock last traded?

The last trade of Poseida Therapeutics, Inc. - Common Stock was at 01/07/25 04:00 PM ET

What is the market capitalization of Poseida Therapeutics, Inc. - Common Stock?

The market capitalization of Poseida Therapeutics, Inc. - Common Stock is 825.70M

How many shares of Poseida Therapeutics, Inc. - Common Stock are outstanding?

Poseida Therapeutics, Inc. - Common Stock has 826M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.